| 26.004 0.594 (2.34%) | 06-09 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term | |
|||
| Targets | 6-month : | 30.57 |
1-year : | 35.71 |
| Resists | First : | 26.18 |
Second : | 30.57 |
| Pivot price | 25 |
|||
| Supports | First : | 24.83 |
Second : | 24 |
| MAs | MA(5) : | 25.35 |
MA(20) : | 24.86 |
| MA(100) : | 25.82  |
MA(250) : | 29.13 |
|
| MACD | MACD : | 0.1 |
Signal : | 0 |
| %K %D | K(14,3) : | 78.9 |
D(3) : | 72.4 |
| RSI | RSI(14): 61.4 |
|||
| 52-week | High : | 34.09 | Low : | 23 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.[ HEAL ] has closed above the upper band by 7.6%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 32% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 26.21 - 26.32 | 26.32 - 26.42 |
| Low: | 25.22 - 25.33 | 25.33 - 25.45 |
| Close: | 25.82 - 26 | 26 - 26.18 |
The Global X HealthTech ETF (HEAL) endeavors to achieve investment performance that broadly tracks the comprehensive returns, derived from both capital appreciation and income, of the Global X HealthTech Index, measured before any fees and operational expenses are taken into account.
Mon, 08 Jun 2026
Medicine's Not Going Anywhere: 3 of the Most Resilient Healthcare ETFs - AOL.com
Thu, 21 May 2026
Medicine's Not Going Anywhere: 3 of the Most Resilient Healthcare ETFs - The Globe and Mail
Thu, 21 May 2026
Medicine's Not Going Anywhere: 3 of the Most Resilient Healthcare ETFs - The Motley Fool
Fri, 15 May 2026
The Next Big Theme: May 2026 - Global X ETFs
Mon, 23 Mar 2026
The Next Big Theme: March 2026 - Global X ETFs
Wed, 18 Feb 2026
The Next Big Theme: February 2026 - Global X ETFs
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NASDAQ
|
|
|
Sector:
Financial Services
|
|
|
Industry:
Asset Management - Global
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 0 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|